Outlook Therapeutics, Inc. (OTLK) — Insider Trading
Insider trading activity for Outlook Therapeutics, Inc. sourced from SEC EDGAR Form 4 filings.
Overview
- Total insider trades: 13
- Last trade date: Sep 2, 2026
- Ticker: OTLK
Top Insiders
- Lundquist Kevin Michael (Chief Financial Officer) — 1 trades, buy: $0, sell: $0
- Sukhtian Ghiath M. — 7 trades, buy: $5.0M, sell: $0
- HILZINGER KURT J — 1 trades, buy: $177K, sell: $0
- Sukhtian Faisal Ghiath — 1 trades, buy: $50K, sell: $0
- Haddadin Yezan Munther — 2 trades, buy: $39K, sell: $0
Recent Trades
| Date | Insider | Ticker / Company |
Type | Shares | Value |
| Sep 1, 2026 |
Lundquist Kevin Michael |
OTLK Outlook Therapeutics, Inc. |
BUY |
500,000 |
N/A |
| Jun 2, 2026 |
Haddadin Yezan Munther |
OTLK Outlook Therapeutics, Inc. |
BUY |
29,000 |
$24K |
| May 28, 2026 |
Sukhtian Ghiath M. |
OTLK Outlook Therapeutics, Inc. |
OTHER |
8,571,428 |
N/A |
| May 28, 2026 |
Sukhtian Ghiath M. |
OTLK Outlook Therapeutics, Inc. |
OTHER |
8,571,428 |
N/A |
| May 28, 2026 |
Sukhtian Ghiath M. |
OTLK Outlook Therapeutics, Inc. |
OTHER |
3,458,571 |
N/A |
| May 28, 2026 |
Sukhtian Ghiath M. |
OTLK Outlook Therapeutics, Inc. |
OTHER |
3,458,571 |
N/A |
| May 28, 2026 |
Sukhtian Ghiath M. |
OTLK Outlook Therapeutics, Inc. |
OTHER |
3,458,571 |
N/A |
| May 28, 2026 |
Sukhtian Ghiath M. |
OTLK Outlook Therapeutics, Inc. |
OTHER |
3,458,571 |
N/A |
| May 28, 2026 |
Sukhtian Ghiath M. |
OTLK Outlook Therapeutics, Inc. |
BUY |
8,539,709 |
$5.0M |
| May 26, 2026 |
HILZINGER KURT J |
OTLK Outlook Therapeutics, Inc. |
BUY |
400,000 |
$177K |
| May 26, 2026 |
THURMAN RANDY H |
OTLK Outlook Therapeutics, Inc. |
BUY |
5,000 |
$2K |
| May 26, 2026 |
Haddadin Yezan Munther |
OTLK Outlook Therapeutics, Inc. |
BUY |
34,000 |
$15K |
| May 27, 2026 |
Sukhtian Faisal Ghiath |
OTLK Outlook Therapeutics, Inc. |
BUY |
122,174 |
$50K |
← All companies · Full trades feed
